My main reason for hoping that they'll be informing the market soon that they have in fact received the green light from the FDA and launched the studies is because I think it will help IPCI get through the past 6 months of market apathy.
But with that said, I totally agree with you that a positive completion of said studies, a new AdCom and PDUFA date scheduled/granted will definitely provide a share price boost...& I think the main reason we continue to not being in a position yet to break out of the 6 month extended market apathy phase...is due to the market masses still wanting & waiting to see real progressive steps being made in their pipeline that may lead to positive outcomes as this year unfolds.
So whether it's IPCI being in a position soon to be able to inform the market that they've launched the oral and nasal studies, or launched the PODRAS human trials, or received FDA approval on Lamictal or Pristiq, or secured some sort of licensing deal in China etc...the market's definitely waiting to see real material progress being made before a renewed optimism phase can begin and we can finally put the market apathy phase behind us.
I'm optimistic now because I'm still holding IPCI and am just thankful that some much needed light finally appears to be approaching on the near term horizon...but for others just passively watching IPCI from the sidelines, who knows what material progress it's truly gonna take for IPCI to finally put the extended market apathy behind them.
At least we know earnings is most likely 2 weeks away so we don't have long to wait until more news arrives.
News 
Market Data 
Discover 
